Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition by William Frishman, Domenic Sica – Ebook PDF Instant Download/Delivery: 0979016436, 978-0979016431
Full download Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd edition after payment
Product details:
ISBN 10: 0979016436
ISBN 13: 978-0979016431
Author: William Frishman, Domenic Sica
EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO KNOW ABOUT DRUG THERAPY FOR CARDIOVASCULAR DISEASE
A critically acclaimed classic reference now in its third edition, Cardiovascular Pharmacotherapeutics, provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such cardiovascular therapeutics, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states.
Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Table of contents:
Part 1: Introduction
1. Basic Principles of Clinical Pharmacology Relevant to Cardiology
2. The Placebo Effectin the Treatment of Cardiovascular Disease
3. Importance of Medication Adherencein Cardiovascular Disease Treatment
4. Health Economic Considerationsin Cardiovascular Drug Utilization
Part 2: Drug Classes
5. Alpha- and Beta-Adrenergic Blocking Drugs
6. Central and Peripheral Sympatholytics
7. Cholinergic and Anticholinergic Drugs
8. Calcium Channel Blockers
9. The Renin-Angiotensin Axis
10. The Renin-Angiotensin Axis
11. Diuretic Therapyin Cardiovascular Disease
12. Magnesium, Potassium, and Calciumas Cardiovascular Disease Therapies
13. Inotropic Agents
14. The Organic Nitrates and Nitroprusside
15. Ranolazine
16. Nonspecific Antihypertensive Vasodilators
17. Antiarrhythmic Drugs
18. Antiplatelet and Other Antithrombotic Drugs
19. Thrombolytic Agents
20. Lipid-Lowering Drugs
21. New Aspects of Combination Therapy
22. Pharmacotherapy for Smoking Cessation
23. Pharmacotherapy of Obesity
24. Heart Disease and Treatmentof Diabetes Mellitus
25. Prostacyclins, Endothelin Inhibitors,and Phosphodiesterase-5 Inhibitorsin Pulmonary Hypertension
26. Selective and Nonselective Dopamine-Receptor Agonists
27. Natriuretic Peptides
28. Vasopressin and Vasopressin Receptor Antagonists
29. Drug-Eluting Stents
Part 3: Special Topics
30. Alternative and ComplementaryMedicine for Preventing and TreatingCardiovascular Disease
31. Cardiovascular Drug–Drug Interactions
32. Pediatric Cardiovascular Pharmacology
33. Drug Therapy of Cerebrovascular Disease
34. Drug Treatment of Peripheral Vascular Disorders
35. Drug Treatment and Prevention of Infective Endocarditis and Rheumatic Fever
36. Cytokines and Myocardial Regeneration
37. Cardiovascular Drugs in Development
Part 4: Appendices
Appendix 1: Pharmacokinetic Properties of Approved Cardiovascular Drugs
Appendix 2: Therapeutic Use of Available Cardiovascular Drugs
Appendix 3: Guide to Cardiovascular Drug Use in Pregnancy and with Nursing
Appendix 4: Dosing Recommendations of Cardiovascular Drugs in Patients with Hepatic Disease and/or
Appendix 5: Dose Adjustment in Patients with Renal Insufficiency
Appendix 6: Selected Cardiovascular Medications and Gender Issues
Appendix 7: Pharmacokinetic Changes, Route of Elimination, and Dosage Adjustment of Selected Cardio
Appendix 8: Selected Cardiovascular Medications and Ethnic Issues
Index
People also search for Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd:
cardiovascular pharmacology textbook
cardiovascular pharmacology journal
cardiovascular drugs pharmacology pdf
cardiovascular pharmacology
cardiovascular pharmacy
Tags: William Frishman, Domenic Sica, Cardiovascular Pharmacotherapeutics